QT
STOK icon

Quantbot Technologies’s Stoke Therapeutics STOK Stock Holding History

Quantbot Technologies’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-88
Closed -$2.79K – 2141
2025
Q4 		$2.79K Buy
+88
New +$2.65K ﹤0.01% 1634
2023
Q1 		– Sell
-3,291
Closed -$30.4K – 2038
2022
Q4 		$30.4K Buy
+3,291
New +$34.2K ﹤0.01% 1386
2022
Q2 		– Sell
-4,300
Closed -$90K – 2113
2022
Q1 		$90K Buy
4,300
+2,900
+207% +$58.1K 0.01% 1071
2021
Q4 		$33K Buy
1,400
+200
+17% +$4.77K ﹤0.01% 1137
2021
Q3 		$30K Buy
1,200
+1,000
+500% +$27.9K ﹤0.01% 1201
2021
Q2 		$6K Hold
200
– – ﹤0.01% 1349
2021
Q1 		$7K Hold
200
– – ﹤0.01% 1278
2020
Q4 		$12K Hold
200
– – ﹤0.01% 1084
2020
Q3 		$6K Buy
+200
New +$5.71K ﹤0.01% 1171

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Quantbot Technologies's STOK Position: Q1 2026 in Review

Quantbot Technologies sold out of Stoke Therapeutics (STOK) in Q1 2026, closing a stake of 88 shares — an estimated $2.79K sold.

Quantbot Technologies first reported a position in STOK in Q3 2020 and held it in 9 quarters. The position peaked at $90K in Q1 2022. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Quantbot Technologies reported no remaining Stoke Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 88 Stoke Therapeutics shares in Q1 2026, an estimated $2.79K.
  • Quantbot Technologies first reported a position in Stoke Therapeutics in Q3 2020 and held it in 9 quarters.
  • Quantbot Technologies's Stoke Therapeutics position peaked at $90K in Q1 2022.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.